Last reviewed · How we verify
tiazesim
tiazesim is a drug. It is currently in unknown development.
Tiazesim is a small molecule heterocyclic antidepressant related to tricyclic antidepressants (TCAs). It was previously sold under the brand name Altinil, introduced in 1966 by Squibb Corporation, but is no longer marketed.
At a glance
| Generic name | tiazesim |
|---|---|
| Therapeutic area | Other |
| Phase | unknown |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tiazesim CI brief — competitive landscape report
- tiazesim updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about tiazesim
What is tiazesim?
tiazesim is a pharmaceutical drug.
What development phase is tiazesim in?
tiazesim is in unknown.
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing